Philips new drag-and-drop oncology software

PHILIPSThe current Pinnacle system combines AcQSim simulation, Syntegra image fusion and P3IMRT modules to provide a powerful oncology toolbox capable of sculpting radiation doses to tumors. The new MBS software offers a revolutionary advancement in reducing the time it takes to contour tumors and anatomical structures and is a crucial step toward the future of IGRT and the ability to quickly adapt patients' treatment plans based on their response to daily treatment.

The MBS software includes an anatomical library of 3D patient organ structure models. Users can simply drag and drop the models onto patient image data and the software automatically adapts to each patient’s anatomy. The library of anatomical models grows as new patient data are added, providing a unique ability to build a library based on regional demographic or clinical practice specialties.

"Philips investment in research and clinical IGRT partnerships has paid off with the launch of MBS," said Philips project manager David Robinson, a Certified Medical Dosimetrist. "IGRT workflow is enhanced by allowing clinicians to quickly contour the tumors and organs at risk in three dimensions, then propagate the organs to alternate 4D datasets to help physicians determine the extent of tumor movement within the patient. This capability opens up the possibility to adapt the daily treatment plan on the fly."

In addition to MBS and its time-saving benefits, Philips has introduced other workflow enhancements such as P3PC for remote planning, which allows Philips clinical customers to remotely access their patient data at more than 1,600 installed Pinnacle sites around the world. While remote patient contouring and treatment planning offer workflow efficiencies today, future adaptive IGRT planning will depend on these remote collaboration tools in order for oncologists to review and interact with their patients' 4D data and daily response to treatment.

Brilliance CT Big Bore: More than 100 Installed and New Features Added
Building on Philips legacy of innovation in CT simulation, the Brilliance CT Big Bore oncology configuration was designed specifically for use in radiation oncology and is already in place at more than 100 clinical sites, including some of the most prominent healthcare facilities worldwide.

New 4D tools have been added to the Philips-exclusive Tumor LOC application, allowing the user to assess motion of respiratory correlated studies. The ability to review patients' breathing patterns and easily draw contours encompassing the range of motion over the entire respiratory cycle simplifies this complex procedure. Advanced 4D tools such as dynamic digitally reconstructed radiographs (DRR) and digitally composited radiographs (DCR) allow visualization of respiratory motion from a beam's eye view perspective. The interconnected Brilliance Workspace allows users to easily evaluate multi-phasic volumetric datasets. With new evaluation tools such as intensity projections over time, dynamic slab viewing and user-defined phase selections, novel treatment options are now possible. These new views assist physicians in determining where a tumor has moved over time, giving them flexibility in choosing treatment-planning options.

Philips new Brilliance CT Big Bore delivers clinical insight through tighter integration with the LAP laser system. Direct connection between the scanner and the laser system reduces the chance of error and makes the absolute marking procedure more automated and easier to use than ever before. In addition, the Brilliance CT Big Bore includes, as standard, a couch and therapy tabletop that meets requirements of the AAPM Task Group 66.

Extended display field of view is another new enhancement debuting at the AAPM meeting. Provided at the request of clinicians, extended display field of view allows users to visualize outside the standard true 60cm SFOV to help avoid untargeted areas during treatment planning.

With the largest installed base of oncology scanners in North America and systems installed in seven of the top 10 cancer treatment centers in the United States, as ranked by US News & World Report Best Hospitals, Philips offers one of the most complete and advanced lines of integrated radiation oncology solutions in imaging, simulation and planning.

For further information, please contact:
Steve Kelly, Senior Public Relations Manager
Tel: +1 425-487-7479
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Ian Race, Public Relations Manager
Tel: +1 978-659-4624
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is one of the world's biggest electronics companies and Europe's largest, with sales of $37.7 billion (EUR 30.4 billion) in 2005. With activities in the three interlocking domains of healthcare, lifestyle and technology and 158,000 employees in more than 60 countries, it has market leadership positions in medical diagnostic imaging and patient monitoring, color television sets, electric shavers, lighting and silicon system solutions. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...